Supriya Lifescience Limited has received a certificate confirming compliance with Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026. The certificate was issued by MUFG Intime India Private Limited, the company's Registrar and Share Transfer Agent. The announcement, dated July 9, 2026, details that the registrar confirmed the dematerialization of securities during the specified quarter. They also confirmed that the securities received from depository participants were processed, and the certificates were either accepted or rejected by the depositories. Furthermore, the registrar verified that the security certificates received for dematerialization were mutilated and cancelled after due verification by the depository participant, and the depositories' names were substituted in the register of members within the prescribed timelines. The company has requested this information be taken on record.
